PARP1 and breast cancer: Additionally, STING agonism in breast cancer gene-1 (BRCA-1) deficient BC mouse model reprograms M2 macrophages to antitumor M1 macrophages, enhances the antitumor function of DCs, and synergizes the anticancer effects of PARP-inhibitors (PARP-Is) [203, 204].